Skip to main content
. 2017 Oct 6;8(56):95999–96012. doi: 10.18632/oncotarget.21625

Figure 6.

Figure 6

(A) Caspase-3/7 activity in human melanoma A375 cells treated with GI50 of Diphyllin and derivatives at different incubation periods (24, 48 and 72h). Pac= paclitaxel (positive control). (B) Densitometric evaluation of the expression levels of Bax/Bcl-2 proteins normalised to β-actin and changes in Bax/Bcl-2 ratio, CPT= camptothecin (positive control). (C) Immunoblot images of their expression in human melanoma A375 cells after 48h treatment with GI50 of Justicidin B, Diphyllin methyl ether (DiME), Diphyllin apioside (DiA), and Diphyllin acetylapioside (DiAA). Data are presented as the mean ±SD (n=3).